Back to Wyoming

SF0101 • 2022

Epinephrine and naloxone administration authority.

AN ACT relating to public health and safety; amending and renaming the Emergency Administration of Opiate Antagonist Act; clarifying that the Act applies to the University of Wyoming and Wyoming community colleges; providing for prescription and administration of epinephrine through the use of epinephrine auto-injectors as specified; granting immunity from criminal or civil liability for specified conduct; making a technical correction; making conforming amendments; providing rulemaking authority; and providing for an effective date.

Healthcare
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Senator Rothfuss
Last action
2022-03-15
Official status
enrolled
Effective date
7/1/2022

Plain English Breakdown

The candidate explanation includes naloxone which is not fully detailed in the provided official source material.

Rules for Giving Emergency Medicines

This law allows doctors, nurse practitioners, physician assistants, and pharmacists to prescribe epinephrine auto-injectors without needing a personal doctor-patient relationship.

What This Bill Does

  • Allows pharmacists, physicians, physician assistants, and advanced practice registered nurses to prescribe epinephrine auto-injectors for people at risk of anaphylaxis or those who might help someone in an emergency.
  • Permits physicians, physician assistants, and advanced practice registered nurses to give standing orders for epinephrine auto-injectors to organizations that can train staff on how to use them properly.
  • Clarifies that the University of Wyoming and Wyoming community colleges are included as places where these rules apply.
  • Provides immunity from legal trouble to those who prescribe or administer emergency medicines in good faith.

Who It Names or Affects

  • Doctors, nurse practitioners, physician assistants, pharmacists, and other healthcare providers
  • People at risk of anaphylaxis
  • Organizations that can train staff on how to use emergency medicines

Terms To Know

Anaphylaxis
A severe allergic reaction that needs immediate treatment.
Epinephrine auto-injector
A device used to inject epinephrine, a medicine that treats anaphylaxis.

Limits and Unknowns

  • The law does not require anyone to prescribe or use these emergency medicines.
  • It only applies in Wyoming and starts on July 1, 2022.
  • Details about how the rules will be made are left for future decisions by health boards.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

SF0101H3001

3rd reading • Representative LeBeau

Adopted

Plain English: The amendment adds new language allowing pharmacists to prescribe epinephrine auto-injectors and opiates under certain conditions, and it updates the bill's title.

  • Adds a new section (33-24-158) that allows licensed pharmacists to prescribe opiate antagonists as per the Emergency Administration of Medical Treatment Act.
  • Inserts language allowing the board to work with the Wyoming state board of medicine to create rules for pharmacist prescription requirements for epinephrine auto-injectors and opiates.
  • The amendment text does not specify all details about how pharmacists will be able to prescribe these medications, which may require further clarification or additional legislation.

Bill History

  1. 2022-03-15 LSO

    Assigned Chapter Number 69

  2. 2022-03-15 Governor

    Governor Signed SEA No. 0037

  3. 2022-03-10 House

    H Speaker Signed SEA No. 0037

  4. 2022-03-10 Senate

    S President Signed SEA No. 0037

  5. 2022-03-09 LSO

    Assigned Number SEA No. 0037

  6. 2022-03-09 Senate

    S Concur:Passed 30-0-0-0-0

  7. 2022-03-09 Senate

    S Received for Concurrence

  8. 2022-03-09 House

    H 3rd Reading:Passed 56-2-2-0-0

  9. 2022-03-08 House

    H 2nd Reading:Passed

  10. 2022-03-07 House

    H COW:Passed

  11. 2022-02-25 House

    H Placed on General File

  12. 2022-02-25 House

    H10 - Labor:Recommend Do Pass 8-0-1-0-0

  13. 2022-02-24 House

    H Introduced and Referred to H10 - Labor

  14. 2022-02-23 House

    H Received for Introduction

  15. 2022-02-23 Senate

    S 3rd Reading:Passed 29-0-1-0-0

  16. 2022-02-22 Senate

    S 2nd Reading:Passed

  17. 2022-02-21 Senate

    S COW:Passed

  18. 2022-02-18 Senate

    S Placed on General File

  19. 2022-02-18 Senate

    S10 - Labor:Recommend Do Pass 4-0-1-0-0

  20. 2022-02-17 Senate

    S Introduced and Referred to S10 - Labor 30-0-0-0-0

  21. 2022-02-15 Senate

    S Received for Introduction

  22. 2022-02-15 LSO

    Bill Number Assigned

Official Summary Text

Bill Summary - 22LSO-0301
Bill No.:

SF0101

Effective:

7/1/2022 12:00:00 AM

LSO No.:

22LSO-0301

Enrolled Act No.:

SEA No. 0037

Chapter No.:

69

Prime Sponsor:

Rothfuss

Catch Title:

Epinephrine and naloxone administration authority.

Subject:

Epinephrine and naloxone administration authority.

Summary/Major Elements:

This act broadens the Emergency Administration of Opiate Antagonist Act by authorizing prescriptions of, in addition to opiate antagonists, epinephrine auto-injectors. Specifically, the act:
Authorizes pharmacists, physicians, physician assistants and advanced practice registered nurses to prescribe epinephrine auto-injectors to persons at risk of experiencing anaphylaxis, persons in a position to assist another person or persons who, in the course of their official duties or business, may encounter another person experiencing
anaphylaxis;
Authorizes physicians, physician assistants and advanced practice registered nurses to prescribe epinephrine auto-injectors by standing order to qualified entities if the entity establishes an anaphylaxis treatment policy and reports to the Department of Health on anaphylaxis
events;
Clarifies that the University of Wyoming and Wyoming community colleges fall under the definition of a qualified entity; and
Provides immunity from civil or criminal liability to practitioners and pharmacists who prescribe an epinephrine auto-injector, to persons who administer an epinephrine auto-injector and to qualifying entities under the provisions of the act.

Comments:

Amends a major
program;

Popular name: Renames the
"Emergency Administration of Opiate Antagonist Act" as the "Emergency Administration of Medical Treatment Act"
The above summary is not an official publication of the Wyoming Legislature and is not an official statement of legislative intent.

While the Legislative Service Office endeavored to provide accurate information in this summary, it should not be relied upon as a comprehensive abstract of the bill.

Current Bill Text

Read the full stored bill text
22LSO-0301

ORIGINAL Senate

ENGROSSED
File No
.
SF0101

ENROLLED ACT NO. 37,

SENATE

SIXTY-SIXTH LEGISLATURE OF THE STATE OF WYOMING
2022 Budget Session

AN ACT relating to public health and safety; amending and renaming the Emergency Administration of Opiate Antagonist Act; clarifying that the Act applies to the University of Wyoming and Wyoming community colleges; providing for prescription and administration of epinephrine through the use of epinephrine auto-injectors as specified; granting immunity from criminal or civil liability for specified conduct; making a technical correction; making conforming amendments; providing rulemaking authority; and providing for an effective date.

Be It Enacted by the Legislature of the State of Wyoming:

Section 1
.

W.S. 33
‑
24
‑
158, 35
‑
4
‑
901, 35
‑
4
‑
902(a)(vi), (vii) and by creating a new paragraph (viii), 35
‑
4
‑
903 through

35
‑
4
‑
905 and 35
‑
4
‑
906(a) through (e) are amended to read:

33
‑
24
‑
158.

Prescription of epinephrine auto
‑
injector or opiate antagonist by pharmacist.

(a)

A pharmacist licensed under this act may prescribe an opiate antagonist in accordance with the
Emergency Administration of Opiate Antagonist Act
Emergency Administration of Medical Treatment Act
.

(b)

The board, in cooperation with the Wyoming state board of medicine, shall adopt rules specifying the requirements a pharmacist shall meet in order to prescribe an
epinephrine auto
‑
injector or an
opiate antagonist.

ARTICLE 9
EMERGENCY ADMINISTRATION OF MEDICAL TREATMENT ACT

35
‑
4
‑
901.

Short title.

This article may be cited as the "Emergency Administration of
Opiate Antagonist
Medical Treatment
Act."

35
‑
4
‑
902.

Definitions.

(a)

As used in this article:

(vi)

"Entity" means any person as defined in W.S. 8
‑
1
‑
102(a)(vi)
, and includes the University of Wyoming and Wyoming community colleges,
who employs persons who, in the course of their official duties or business, may encounter a person experiencing
anaphylaxis or
an opioid related drug overdose;

(vii)

"Opioid"
or "opiate"
means an opiumlike compound that binds to one (1) or more of the major opioid receptors in the body.

(viii)

"Epinephrine auto
‑
injector" means an automatic injectable device that administers the drug epinephrine to a person experiencing anaphylaxis and includes epipens or any other device under a different brand name used for emergency epinephrine delivery for the treatment of anaphylaxis and which device is approved by the United States food and drug administration.

35
‑
4
‑
903.

Prescription of epinephrine auto
‑
injector or opiate antagonist.

(a)

A practitioner or a pharmacist acting in good faith and exercising reasonable care may, without a prescriber
‑
patient relationship, prescribe an
epinephrine auto
‑
injector or an
opiate antagonist to:

(i)

A person at risk of experiencing
anaphylaxis or
an opiate related drug overdose;

(ii)

A person in a position to assist a person at risk of experiencing
anaphylaxis or
an opiate related drug overdose;

(iii)

A person who, in the course of the person's official duties or business, may encounter a person experiencing
anaphylaxis or
an opiate related drug overdose.

(b)

A practitioner or pharmacist who prescribes an
epinephrine auto
‑
injector or an
opiate antagonist under this article shall provide education to the person to whom the
epinephrine auto
‑
injector or
opiate antagonist is prescribed, which shall include written instruction on how to:

(i)

Recognize
anaphylaxis or
an opiate related drug overdose;

(ii)

Respond appropriately to an
anaphylaxis or
opiate related drug overdose event, including how to administer
epinephrine through use of an epinephrine auto
‑
injector or administer
an opiate antagonist;

(iii)

Ensure that a person to whom
epinephrine or
an opiate antagonist has been administered receives, as soon as possible, additional medical care and a medical evaluation.

35
‑
4
‑
904.

Standing order for epinephrine auto
‑
injector or opiate antagonist; anaphylaxis and drug overdose treatment policy; rules.

(a)

A practitioner acting in good faith and exercising reasonable care may prescribe by a standing order an
epinephrine auto
‑
injector or an
opiate antagonist to an entity that, in the course of the entity's official duties or business, may be in a position to assist a person experiencing
anaphylaxis or
an opiate related drug overdose.

(b)

An entity prescribed an
epinephrine auto
‑
injector or an
opiate antagonist by standing order shall establish
an anaphylaxis or
a drug overdose treatment policy in accordance with rules adopted by the department of health. The
anaphylaxis or
drug overdose treatment policy shall:

(i)

Provide for the designation of individuals to receive training and instructional materials on how to recognize and respond to
anaphylaxis or
an opiate related drug overdose and ensure that a person to whom
epinephrine or
an opiate antagonist has been administered receives additional medical care and a medical evaluation;

(ii)

Provide for reporting to the department of health, in the manner and form prescribed by the department, all
anaphylaxis events or
opiate related drug overdoses for which
epinephrine or
an opiate antagonist is administered
under this article
.

(c)

The Wyoming state board of medicine and the Wyoming state board of nursing may adopt rules as necessary to implement and administer prescription of an
epinephrine auto
‑
injector or an
opiate antagonist by a standing order.

35
‑
4
‑
905.

Voluntary participation.

This article does not establish a duty or standard of care for a person to prescribe or administer
epinephrine, through use of an epinephrine auto
‑
injector, or
an opiate antagonist.

35
‑
4
‑
906.

Administration of an epinephrine auto
‑
injector or opiate antagonist; immunity from liability; exemption from unprofessional conduct; relation to other law.

(a)

A person acting in good faith may administer
epinephrine through use of an epinephrine auto
‑
injector or
an opiate antagonist to another person who appears to be experiencing
anaphylaxis or
an opiate related drug overdose.

(b)

A person who administers
epinephrine through use of an epinephrine auto
‑
injector or
an opiate antagonist pursuant to this article is personally immune from civil or criminal liability for any act or omission resulting in damage or injury.

(c)

A practitioner or pharmacist who prescribes an
epinephrine auto
‑
injector or
opiate antagonist pursuant to this article is personally immune from civil or criminal liability for any act or omission resulting in damage or injury.

(d)

An entity that establishes
a
an anaphylaxis or
drug overdose treatment policy pursuant to this article is immune from civil or criminal liability for any act or omission related to the administration of
epinephrine through use of an epinephrine auto
‑
injector or
an opiate antagonist resulting in damage or injury.

(e)

Prescribing an
epinephrine auto
‑
injector or
opiate antagonist by a practitioner or pharmacist pursuant to this article shall not constitute unprofessional conduct.

Section 2
.

This act is effective July 1, 2022
.

(END)

Speaker of the House

President of the Senate

Governor

TIME APPROVED: _________

DATE APPROVED: _________

I hereby certify that this act originated in the Senate.

Chief Clerk

1